氟替美维吸入粉雾剂(Trelegy Ellipta)的副作用和不良反应

In addition to its intended therapeutic effects, Trelegy Ellipta may cause some adverse effects. Although not all of these side effects will occur, if they do, they may require medical attention.

Flutimavir inhalation powder spray (Trelegy Ellipta) side effects of seeking medical attention immediately

1. Less common side effects

Bladder pain, hematuria or cloudy urine, chest pain or chest tightness, chills, cough, diarrhea, difficulty urinating, and burning may occur Burning or aching sensation, fever, frequent urination, headache, loss of appetite, lower back or flank pain, nausea, pain in the nose and mouth, pain or tenderness around the eyes and cheek bones, sneezing, sore throat, stuffy or runny nose, stomach pain, difficulty breathing, and weakness.

Flutimavir inhalation powder (Trelegy Ellipta) has side effects of unknown incidence

There are also other side effects of unknown incidence.

Other side effects of Trelegy Ellipta

Some side effects of Trelegy Ellipta may not usually require medical attention and may disappear during treatment as the body adapts to the drug. Additionally, a health care professional may be able to tell you how to prevent or reduce some side effects.

The pictures are from public channels (such as the official website of the FDA, the official website of the original drug manufacturer, etc.) and are for reference only.

Talk to your doctor about side effects of Trelegy Ellipta

Less common side effects

May include back pain, change in taste, headache, and loss of taste.

Side effects management for medical professionals

1. Gastrointestinal adverse events

Common (incidence 1% to 10%): oropharyngeal pain, diarrhea, gastroenteritis.

2. Musculoskeletal system

Common (incidence 1% to 10%): back pain.

3. Respiratory system

Common (incidence 1% to 10%): cough.

4. Nervous system

Common (incidence 1% to 10%): headache, taste disorder.

The above content only reflects the range of side effects of Flutimavir Inhalation Powder (Trelegy Ellipta) in overseas registered countries. It does not represent the approved use range in mainland China. Please do not make any treatment decisions based on this.